Respiratory Syncytial Virus Infection

• CLINICAL_TRIALS trial_result · 2022-12-19
  Clinical Trial Update: A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women [Phase 2]

  Phase 2 clinical trial evaluating an RSV vaccine alone or with a Tdap vaccine, followed by a second RSV dose, in healthy non-pregnant women;…

• CLINICAL_TRIALS trial_result · 2022-11-30
  Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age [Phase 1, Phase 2]

  This clinical trial update reports results from Phase 1/2 studies assessing safety, reactogenicity, and immunogenicity of the Ad26.RSV.Pre-F…

• CLINICAL_TRIALS trial_result · 2022-08-04
  Clinical Trial Update: Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine [Phase 2]

  Phase 2 human challenge study evaluating MV-012-968 vaccine for respiratory syncytial virus (RSV) infection has completed.

• CLINICAL_TRIALS trial_result · 2022-07-19
  Clinical Trial Update: A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults [Phase 3]

  A Phase 3 clinical trial evaluating an RSV F vaccine in older adults has completed.

• CLINICAL_TRIALS trial_result · 2022-06-29
  Clinical Trial Update: Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study [Phase 2]

  An extension Phase 2 trial evaluating safety and immunogenicity of a revaccination dose of the RSVPreF3 OA investigational vaccine in adults…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-06-08
  Clinical Trial Update: A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease [Phase 2]

  A Phase 2 infant study evaluated early diagnosis of Respiratory Syncytial Virus and the evaluation of JNJ-53718678 in RSV acute respiratory …

• CLINICAL_TRIALS trial_result · 2022-05-27
  Clinical Trial Update: Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year. [Phase 2]

  A Phase 2 trial assessing safety and immunogenicity of the RSV-F vaccine in older adults previously treated with the same vaccine or placebo…

• CLINICAL_TRIALS trial_result · 2022-05-27
  Clinical Trial Update: Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults [Phase 2]

  Phase 2 clinical trial evaluating the safety and immunogenicity of an RSV-F vaccine in elderly adults has completed.

• CLINICAL_TRIALS trial_result · 2022-05-03
  Clinical Trial Update: A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model [Phase 2]

  Phase 2a study evaluating EDP-938 in an RSV infection virus challenge model has been completed with results posted.

• CLINICAL_TRIALS trial_result · 2022-03-23
  Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults [Phase 1, Phase 2]

  A completed Phase 1/Phase 2 trial evaluating the safety, reactogenicity, and immune response of GSK's RSV vaccine candidate GSK3844766A in o…

• CLINICAL_TRIALS trial_result · 2022-02-25
  Clinical Trial Update: A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults [Phase 1]

  Phase 1 trial evaluating safety and immune response of GSK's RSV vaccine candidate in Japanese older adults has completed with results poste…

• CLINICAL_TRIALS trial_result · 2022-01-05
  Clinical Trial Update: MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States [Phase 3]

  Phase 3 trial of MEDI-524 (motavizumab) for RSV prevention in Native American infants completed; results posted in 2022.

• CLINICAL_TRIALS trial_result · 2021-12-06
  Clinical Trial Update: Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults [Phase 2]

  Phase 2 trial update evaluating single- or two-dose RSV F vaccine regimens with or without aluminum phosphate or Matrix-M1 adjuvants in clin…

• CLINICAL_TRIALS trial_result · 2021-10-04
  Clinical Trial Update: Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV [Phase 1]

  Phase 1 exploratory trial assessing prophylactic efficacy of palivizumab in healthy adults inoculated with RSV; completed with results poste…

• CLINICAL_TRIALS trial_result · 2021-08-26
  Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults [Phase 2]

  Phase 2 trial evaluating safety and immunogenicity of an adjuvanted RSV vaccine in healthy older adults; trial terminated with results poste…

• CLINICAL_TRIALS trial_result · 2021-08-18
  Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health [Phase 2]

  Phase 2 trial evaluating the safety and immunogenicity of seasonal influenza vaccine with and without co-administration of Ad26.RSV.preF in …

• CLINICAL_TRIALS trial_result · 2021-08-17
  Clinical Trial Update: A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness [Phase 2]

  Phase 2 study evaluating a single intramuscular dose of motavizumab for RSV illness in young children; trial terminated with results posted …

• CLINICAL_TRIALS trial_result · 2021-07-23
  Clinical Trial Update: An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults [Phase 2]

  An exploratory Phase 2 trial evaluated whether a single dose of the Ad26.RSV.preF vaccine could prophylactically prevent Respiratory Syncyti…

• CLINICAL_TRIALS trial_result · 2021-04-13
  Clinical Trial Update: Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005) [Phase 2]

  Phase 2a human challenge trial of MK-1654 (clesrovimab) in healthy participants has completed with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-01-08
  Clinical Trial Update: Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]

  Phase 1 trial assessing infectivity, safety, and immunogenicity of recombinant live-attenuated RSV vaccines in RSV-seronegative infants aged…

• CLINICAL_TRIALS trial_result · 2020-04-15
  Clinical Trial Update: A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women [Phase 1]

  Phase 1 trial evaluating different dose levels of an investigational RSV vaccine (GSK3888550A) in healthy non-pregnant women; study complete…

• CLINICAL_TRIALS trial_result · 2019-12-24
  Clinical Trial Update: Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus [Phase 2]

  Phase 2 trial evaluating lumicitabine for RSV in hospitalized adults; study terminated with results posted in 2019.

• CLINICAL_TRIALS trial_result · 2019-12-05
  Clinical Trial Update: A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus [Phase 2]

  Phase 2 trial evaluating lumicitabine (JNJ-64041575) in hospitalized infants and children with respiratory syncytial virus; study terminated…

• CLINICAL_TRIALS trial_result · 2019-02-19
  Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health [Phase 1]

  Phase 1 study evaluating the safety, tolerability, and immunogenicity of two vaccinations of Ad26.RSV.preF given one year apart in adults ag…

• CLINICAL_TRIALS trial_result · 2019-02-12
  Clinical Trial Update: Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects [Phase 1]

  Phase 1 study assessed potential drug-drug interactions when co-administering EDP-938 with cyclosporine and prednisone in healthy adult subj…